Genetic Testing (PGT/PGD) in Lucknow: How Embryo Screening Transforms Your IVF Journey

Preimplantation Genetic Testing (PGT) is an umbrella term for laboratory procedures that screen embryos created through IVF before they are transferred to the uterus. It is divided into three main subtypes: PGT-A (formerly PGS) screens for aneuploidy — abnormal chromosome numbers; PGT-M (formerly PGD) detects specific monogenic or single-gene disorders; and PGT-SR identifies structural chromosomal rearrangements such as translocations.

The process begins after a standard IVF cycle in which eggs are fertilised and cultured to the blastocyst stage, usually by day 5 or 6. A trained embryologist performs a trophectoderm biopsy — removing 5–8 cells from the outer layer of the blastocyst while leaving the inner cell mass, which forms the baby, completely intact. These cells are then sent to a specialist genetics laboratory where techniques such as Next Generation Sequencing (NGS) or array Comparative Genomic Hybridisation (aCGH) analyse the chromosomal and genetic content with high precision.

Embryo transfer is scheduled only after results confirm a euploid (chromosomally normal) or unaffected embryo, significantly increasing the probability of a healthy, ongoing pregnancy. The HomeIVF Medical Board reviews each case to ensure testing protocols are aligned with international ESHRE and PGDIS guidelines.

Not every IVF cycle requires PGT, but several clinical profiles make genetic testing strongly advisable. Couples in Lucknow who have experienced two or more unexplained IVF failures are prime candidates, since chromosomal aneuploidy in embryos is the single largest cause of failed implantation globally. Similarly, women above the age of 35 — a growing demographic in Aliganj and Gomti Nagar's professional communities — face a significantly higher rate of chromosomally abnormal eggs, making PGT-A a valuable tool to identify transferable embryos.

Recurrent pregnancy loss (three or more miscarriages) often has a chromosomal basis. PGT-A can identify euploid embryos and reduce the heartbreaking cycle of biochemical or clinical pregnancy loss. Couples where one or both partners carry a known hereditary condition — such as beta-thalassaemia (common in Uttar Pradesh's population), spinal muscular atrophy (SMA), cystic fibrosis, or a chromosomal translocation — benefit specifically from PGT-M or PGT-SR to ensure their child is unaffected.

Men with severely low sperm counts or high sperm DNA fragmentation are also candidates, since poor sperm quality correlates with higher rates of chromosomally abnormal embryos. The HomeIVF Medical Board conducts thorough eligibility assessments before recommending any genetic testing pathway.

Genetic causes of infertility or recurrent pregnancy loss are often 'invisible' — there are no obvious external symptoms. However, certain patterns should prompt a conversation with a fertility specialist about genetic evaluation. Multiple IVF failures with good-quality embryos on Day 3 assessment — yet failures at implantation — strongly suggest chromosomal issues that Day 3 grading cannot detect.

A personal or family history of chromosomal conditions, early menopause, or children born with genetic syndromes warrants carrier screening before or during IVF. Women who experience repeated first-trimester losses, often mistaken for 'bad luck', should be evaluated for embryonic chromosomal abnormalities. Men whose semen analysis reveals azoospermia or severe oligospermia may carry Y-chromosome microdeletions or Klinefelter syndrome.

For families in Lucknow with a known thalassaemia carrier status — a relatively high-prevalence condition in the Uttar Pradesh region — PGT-M can prevent transmission to future children, eliminating the need for prenatal diagnosis and the difficult decisions it sometimes entails. Recognising these clinical signals early and discussing them with a HomeIVF-affiliated specialist can save both time and emotional cost.

A thorough pre-testing workup is essential before initiating a PGT cycle. The HomeIVF Medical Board recommends a structured diagnostic pathway for Lucknow patients that includes karyotyping of both partners (a blood test that maps chromosomal structure), carrier screening panels for common autosomal recessive conditions prevalent in the Indian population, and sperm DNA fragmentation testing for the male partner.

For couples pursuing PGT-M for a specific single-gene disorder, the genetics laboratory must first conduct a 'workup' phase — typically taking 8–12 weeks — where probes or reference sequences specific to the family's mutation are developed. This step is non-negotiable for accuracy and should not be bypassed in the interest of speed.

Amniotic fluid testing (amniocentesis) or chorionic villus sampling (CVS) is not replaced by PGT but may still be recommended as a confirmatory test in certain high-risk scenarios, per established clinical guidelines. Genetic counselling sessions — conducted via HomeIVF's teleconsultation platform — help Lucknow couples from Hazratganj, Indira Nagar, and outlying talukas understand their results, implications, and options without the logistical burden of multiple clinic visits.

The PGT journey integrates seamlessly with a standard IVF cycle but requires additional planning and coordination. Step one involves ovarian stimulation using injectable gonadotropins, with monitoring ultrasounds and blood tests — several of which can be performed at home through HomeIVF's certified nurse network, reducing clinic visits for patients across Lucknow.

Step two is egg retrieval under sedation at a partner clinic, followed by fertilisation (conventional IVF or ICSI, depending on sperm parameters). Step three is embryo culture to blastocyst stage over 5–6 days in a controlled laboratory environment. Step four is the trophectoderm biopsy, performed by a trained embryologist. Biopsied embryos are vitrified (flash-frozen) immediately to preserve their viability while genetic analysis is completed.

Step five involves NGS or aCGH analysis in the genetics laboratory, with results typically available in 10–14 working days. Step six is a frozen embryo transfer (FET) cycle in a subsequent month using a normal (euploid) or unaffected embryo, which is thawed and transferred under ultrasound guidance. The FET protocol is lighter than a full IVF cycle and can largely be managed with home monitoring supported by HomeIVF's platform, minimising disruption to patients' professional and family lives in Lucknow.

Understanding the financial investment involved in PGT is crucial for Lucknow families planning ahead. The cost of genetic testing adds to the base IVF cycle cost, encompassing embryo biopsy charges, laboratory processing fees, and the genetics panel itself. HomeIVF offers transparent IVF packages starting from ₹1.5 lakh, with PGT add-on costs clearly outlined during the initial consultation so there are no hidden surprises.

Timelines vary by testing type. A PGT-A cycle — from stimulation start to embryo transfer — typically spans two to three months when accounting for stimulation, biopsy, freeze-all, genetic analysis, and FET preparation. PGT-M cycles require an additional 8–12 week probe development phase before stimulation even begins, making early planning essential.

It is worth noting that while PGT adds upfront cost, it can reduce overall expenditure across multiple failed IVF cycles by improving single-transfer success rates. For couples who have already spent on two or more failed cycles, the marginal cost of PGT often represents a sound clinical and financial decision. The HomeIVF Medical Board helps each Lucknow couple model their personalised pathway so expectations around both investment and outcomes are realistic from day one.

One of the most overlooked stressors in an IVF-PGT cycle is the sheer volume of clinic visits required — multiple ultrasounds, blood draws for estradiol and LH levels, and medication adjustments during stimulation. For working couples in Gomti Nagar's tech corridors, Hazratganj's commercial district, or Aliganj's residential neighbourhoods, taking repeated half-days off work adds logistical pressure to an already emotionally demanding process.

HomeIVF addresses this through a structured home-monitoring protocol validated by the HomeIVF Medical Board. Certified phlebotomists and sonographers visit patients at home for cycle monitoring appointments during the stimulation phase. Results are uploaded to the HomeIVF platform within hours, and a senior specialist reviews them to issue medication adjustments the same day — replicating the clinical standard of an in-person monitoring visit without the waiting room.

Beyond convenience, this model improves compliance: patients who miss monitoring visits risk over- or under-stimulation, compromising the number and quality of embryos available for biopsy. HomeIVF's digital dashboard also allows couples to track their cycle in real time, access educational resources about PGT, and message their care coordinator — empowering informed participation throughout the process rather than passive waiting.

Despite growing awareness, several barriers prevent Lucknow couples from accessing PGT. The first is geographic: advanced embryo biopsy and next-generation sequencing are available only at a handful of accredited laboratories in India, and many Lucknow patients mistakenly assume they must travel to Delhi or Mumbai. In reality, reputable IVF clinics within Lucknow partner with these national-level genetics laboratories, and sample logistics are handled by the clinical team.

The second barrier is informational: misinformation on social media sometimes frames PGT as 'designer baby' technology or suggests it guarantees a live birth. Honest counselling by the HomeIVF Medical Board clarifies that PGT improves the probability of success by selecting the most viable embryos — it does not create genetic advantages or override natural embryo development limits.

The third barrier is emotional: undergoing genetic analysis can surface anxieties about hereditary disease, carrier status, and identity. HomeIVF's telecounselling and genetic counselling integration ensures couples are supported psychologically as well as medically. Finally, the logistical burden of monitoring visits — a significant deterrent for patients in peripheral Lucknow areas — is eliminated through HomeIVF's home-visit network, making the full PGT-IVF pathway accessible without sacrificing clinical rigour.